Literature DB >> 12960363

Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter.

Sunita K Agarwal1, Elizabeth A Novotny, Judy S Crabtree, Jonathan B Weitzman, Moshe Yaniv, A Lee Burns, Settara C Chandrasekharappa, Francis S Collins, Allen M Spiegel, Stephen J Marx.   

Abstract

Different components of the AP1 transcription factor complex appear to have distinct effects on cell proliferation and transformation. In contrast to other AP1 components, JunD has been shown to inhibit cell proliferation. Also, in prior studies, JunD alone bound menin, product of the MEN1 tumor suppressor gene, and JunD's transcriptional activity was inhibited by menin, suggesting that JunD might achieve all or most of its unique properties through binding to menin. Analyses of JunD and menin effects on proliferation, morphology, and cyclin D1 in stable cell lines unmasked an unexpected growth promoting activity of JunD. Whereas stable overexpression of wild-type (wt) mouse JunD in JunD-/- immortalized fibroblasts inhibited their proliferation and reverted their transformed-like phenotype, overexpression of a missense mouse JunD mutant (mJunDG42E) with disabled binding to menin showed opposite or growth promoting effects. Similarly, stable overexpression of wt mouse JunD in wt immortalized fibroblasts inhibited growth. In contrast, its overexpression in Men1-/- immortalized fibroblasts enhanced their already transformed-like characteristics. To conclude, JunD changed from growth suppressor to growth promoter when its binding to menin was prevented by a JunD mutant unable to bind menin or by Men1-null genetic background.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960363      PMCID: PMC196878          DOI: 10.1073/pnas.1834524100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Differential binding of the Menin tumor suppressor protein to JunD isoforms.

Authors:  O Yazgan; C M Pfarr
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

2.  JunB can substitute for Jun in mouse development and cell proliferation.

Authors:  Emmanuelle Passegué; Wolfram Jochum; Axel Behrens; Romeo Ricci; Erwin F Wagner
Journal:  Nat Genet       Date:  2002-01-02       Impact factor: 38.330

3.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

4.  JunD protects cells from p53-dependent senescence and apoptosis.

Authors:  J B Weitzman; L Fiette; K Matsuo; M Yaniv
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

Review 5.  AP-1 in mouse development and tumorigenesis.

Authors:  W Jochum; E Passegué; E F Wagner
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 6.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

7.  Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.

Authors:  L Bakiri; D Lallemand; E Bossy-Wetzel; M Yaniv
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

8.  Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.

Authors:  Adriana Gallo; Concetta Cuozzo; Ilaria Esposito; Marcello Maggiolini; Daniela Bonofiglio; Adele Vivacqua; Maria Garramone; Carsten Weiss; Dirk Bohmann; Anna Maria Musti
Journal:  Oncogene       Date:  2002-09-19       Impact factor: 9.867

Review 9.  Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1.

Authors:  Ariane Poisson; Barbara Zablewska; Patrick Gaudray
Journal:  Cancer Lett       Date:  2003-01-10       Impact factor: 8.679

10.  Targeted disruption of the murine junD gene results in multiple defects in male reproductive function.

Authors:  D Thépot; J B Weitzman; J Barra; D Segretain; M G Stinnakre; C Babinet; M Yaniv
Journal:  Development       Date:  2000-01       Impact factor: 6.868

View more
  46 in total

1.  Menin induces endodermal differentiation in aggregated P19 stem cells by modulating the retinoic acid receptors.

Authors:  Jyotshnabala Kanungo; Settara C Chandrasekharappa
Journal:  Mol Cell Biochem       Date:  2011-08-11       Impact factor: 3.396

2.  Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).

Authors:  Lucie Canaff; Jean-François Vanbellinghen; Hiroshi Kaji; David Goltzman; Geoffrey N Hendy
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

Review 3.  In search of tumor suppressing functions of menin.

Authors:  Yuqing Yang; Xianxin Hua
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

4.  HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

Authors:  M Terol; H Gazon; I Lemasson; M Duc-Dodon; B Barbeau; R Césaire; J-M Mesnard; J-M Péloponèse
Journal:  Leukemia       Date:  2017-03-06       Impact factor: 11.528

5.  Induced JunD in intestinal epithelial cells represses CDK4 transcription through its proximal promoter region following polyamine depletion.

Authors:  Lan Xiao; Jaladanki N Rao; Tongtong Zou; Lan Liu; Bernard S Marasa; Jie Chen; Douglas J Turner; Antonino Passaniti; Jian-Ying Wang
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

Review 6.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

7.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

Review 8.  Multiple endocrine neoplasia type 1.

Authors:  Sunita K Agarwal
Journal:  Front Horm Res       Date:  2013-03-19       Impact factor: 2.606

Review 9.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

10.  Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.

Authors:  Akihiko Yokoyama; Zhong Wang; Joanna Wysocka; Mrinmoy Sanyal; Deborah J Aufiero; Issay Kitabayashi; Winship Herr; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.